Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data
Clinical and Translational Science · 2024-11 · 17 (11)
DOI: 10.1111/cts.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 18.11.2024. Verfasst von Ali Ekin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey. Hauptthemen laut MEDLINE: Piperidines, Arthritis, Rheumatoid, Pyrimidines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tofacitinib is a targeted JAK inhibitor used to treat rheumatoid arthritis. Despite some recent safety concerns, it is considered effective and safe with appropriate patient selection. Between May 2015 and May 2024, data were retrospectively analyzed from 112 patients with a diagnosis of RA in a tertiary care hospital who had received tofacitinib for at least 1 month, with or without prior biologic DMARDs. The mean disease duration was 12 years, and the median duration of tofacitinib use was 32.5 months. The p ‐value for all disease activity parameters evaluated for effectiveness between the 1st‐ and 3rd‐month visits was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
- Department of Internal Medicine, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
ORCID-Profile: Ali Ekin, Salim Misirci, Selin İldemir, Belkıs Nihan Coskun, Burcu Yagiz, Ediz Dalkilic, Yavuz Pehlivan
Zitieren
APA
Ekin, A., Misirci, S., İldemir, S., Coskun, B. N., Yagiz, B., Dalkilic, E., & Pehlivan, Y. (2024). Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data. Clinical and Translational Science, 17(11). https://doi.org/10.1111/cts.70084
Vancouver
Ekin A, Misirci S, İldemir S, Coskun BN, Yagiz B, Dalkilic E, et al. Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data. Clinical and Translational Science. 2024;17(11). doi:10.1111/cts.70084
BibTeX
@article{Ekin2024,
author = {Ekin, Ali and Misirci, Salim and İldemir, Selin and Coskun, Belkıs Nihan and Yagiz, Burcu and Dalkilic, Ediz and Pehlivan, Yavuz},
title = {Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data},
journal = {Clinical and Translational Science},
year = {2024},
volume = {17},
number = {11},
doi = {10.1111/cts.70084}
}
EUVIMED